Best Agrolife (539660) Q1 25/26 earnings summary

Executive summary

• Q1 FY26 saw a deliberate shift to in-season sales, reducing early placements and inventory, with a focus on patented, high-margin products and operational efficiency.

• Newly launched patented products, including Shot Down, Hustler, and Fetagen, performed well and received strong positive feedback from channel partners and farmers, covering over 500,000 acres.

• International business expanded with new registrations and trials in Africa, Sri Lanka, Australia, and South America.

• Focused on building a leaner, more sustainable business model by reducing early product placements and prioritizing in-season sales.

Financial highlights

• Revenue from operations was INR 381 crore in Q1 FY26, down 27% year-over-year from INR 519 crore, but up 39% sequentially from Q4 FY25.

• Gross margin improved to 30% from 24% year-over-year, with gross profit at INR 111 crore.

• EBITDA was INR 46 crore (down from INR 55 crore), but EBITDA margin expanded by 125-140 bps to 12%.

• Profit after tax remained stable at INR 20 crore, with cash margin rising to 5% from 4%.

• EPS was INR 8.42, slightly lower than INR 9.00 in Q1 FY25.

Outlook and guidance

• Revenue for FY26/27 is guided at INR 1,600-1,700 crore, with annual EBITDA margin expected to exceed 15%.

• Patented products are expected to drive margin expansion and operating leverage.

• Management remains confident in sustaining momentum through the Kharif season, supported by a strong product portfolio and improved margins.

• Sales return target reduced to 10%-12% (from 20%-24% in prior years), supporting profitability.

• Q2 expected to see revenue pickup as seasonal demand materializes.